Sign in
ACRV Stock Price, Chart, Stats & News
Acrivon Therapeutics, Inc. Common Stock
Save
Acrivon Therapeutics, Inc. Common Stock (ACRV) does not currently pay a dividend.
89.88M
Market cap
–
Current P/E
–
Forward P/E
ACRV chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -60.06% |
ROE | -57.23% |
D/E | 0.02x |
Interest coverage ratio | – |
ACRV valuation
P/E | – |
P/S | – |
P/B | 0.46x |
P/CF | -0.80x |
P/FCF | -0.64x |
P/OCF | -0.80x |
PEG | -0.13x |
EV multiple | -0.96x |
About
Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves as a precision medicine tool.
Similar securities
Based on sector and market capitalization
Report issue